Please assess the completion status of the following clinical trial:

Trial Title: Same-day Dilapan-S With Adjunctive Misoprostol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater than or equal to 18 years (no upper age limit)~* Gestational age between 16+0 and 20+6 weeks gestation on day of D\&E with confirmation of gestational age by ultrasound~* Desires D\&E for termination of pregnancy or for fetal demise~* Able to provide written informed consent~* Able to comply with study procedures~* English-speaking~Exclusion Criteria:~* Known allergy or contraindication to misoprostol~* Pregnancy with a multiple gestation~* Known bleeding disorder or current anticoagulation therapy (within one month of procedure)~* Active bleeding or hemodynamically unstable at enrollment~* Signs of chorioamnionitis or clinical infection at enrollment~* Signs of spontaneous labor or cervical insufficiency at enrollment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Misoprostol (Type: EXPERIMENTAL): Misoprostol 400 mcg buccal 3 hours prior to D\&E as an adjunct to same-day Dilapan-S.
- Folic Acid (Type: PLACEBO_COMPARATOR): Folic acid 4 mg buccally 3 hours prior to D\&E as an adjunct to same-day Dilapan-S

Based on this trial design, predict the completion outcome and termination type (if applicable).